Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Real‐world evidence from the non‐interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab
Journal of the European Academy of Dermatology and Venereology, 2022-09, Vol.36 (9), p.1568-1577
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb randomized, double‐blind, parallel‐group, GUIDE study
Journal of the European Academy of Dermatology and Venereology, 2023-10, Vol.37 (10), p.2016-2027
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study
Journal of the European Academy of Dermatology and Venereology, 2023-07
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Online weight-loss coaching for patients with psoriasis: results of a pilot study
British journal of dermatology (1951), 2016-03, Vol.174 (3), p.674-676
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
083 Prolonged Q16W treatment interval of guselkumab is non-inferior to Q8W dosing for maintaining disease control in super responders: primary results from GUIDE at Week 68 in patients with psoriasis
Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S194-S194
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
587 Higher IL-10+ T cell and treg cell counts in psoriatic skin are associated with super-response to guselkumab: Data from the phase 3 guide trial
Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S101-S101
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Prognostic factors for early PASI 100 response in psoriasis patients treated with guselkumab: Results from the GUIDE study
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, Vol.87 (3), p.AB195
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Early disease intervention in psoriasis leads to a faster and higher rate of complete skin clearance: Week 28 results from the GUIDE study
EXPERIMENTAL DERMATOLOGY, 2021, Vol.30, p.34
2021
Volltextzugriff (PDF)
1 – 8 von 8
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen